Therapeutic targeting of oncogenic KRAS in pancreatic cancer by engineered exosomes

Exosomes, the smallest (30–150 nm in diameter) subset of extracellular vesicles (EVs) are derived from the endocytic compartment of the parent cell and function as an inter-cellular communication system (1).